Selective inactivation of cytotoxic T lymphocytes in long-term renal transplant recipients: clonal anergy as a possible mechanism underlying allograft acceptance.
Fujiwara
T
T
Department of Transplantation surgery, Center for Adult Diseases, Kurashiki, Japan.
Sakagami
K
K
Saitoh
S
S
Uda
M
M
Kusaka
S
S
Nakagawa
K
K
Matsuno
T
T
Orita
K
K
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001806:Blood Urea Nitrogen; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D017635:Clonal Anergy; D003404:Creatinine / Q000097:blood; D005260:Female; D005434:Flow Cytometry; D005500:Follow-Up Studies; D006650:Histocompatibility Testing; D006801:Humans; D007376:Interleukin-2 / Q000096:biosynthesis; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D010290:Parents; D011897:Random Allocation; D015375:Receptors, Interleukin-2 / Q000096:biosynthesis; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D013997:Time Factors; D014019:Tissue Donors
D007376:Interleukin-2; D015375:Receptors, Interleukin-2; D003404:Creatinine; D001379:Azathioprine; D008775:Methylprednisolone